Novartis reviews media: report

Share this article:
Novartis is launching a global media review, reported Advertising Age. The incumbent media shop is WPP's MEC, the magazine said, noting that in 2008, the company shifted its media business from WPP's Mindshare into MEC.
Novartis said in an email response: “We regularly evaluate suppliers, but have made no decision to change our media agency relationship at this time.” Ad Age cited “several industry executives” as saying the review was imminent and an RFP would go out shortly. GSK and Pfizer have reviewed their media planning and buying businesses recently, and with cost-cutting initiatives on at most major pharmas, they won't be the last.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.